Ledger.Open graph →
SEC Form D · filed August 30, 2019

ESSA Pharma Inc

Offering
$36.0M
Sold
$36.0M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
Vancouver, British Columbia, Canada
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (16)

Franklin Berger · San Francisco, CADirectorGary Sollis · Vancouver, British Columbia, CanadaDirectorRichard Glickman · Vancouver, British Columbia, CanadaDirectorDavid Parkinson · Gaithersburg, MDExec · DirectorDavid Wood · Langley, British Columbia, CanadaExecSandy M. Zweifach · Sausalito, CADirectorScott Requadt · Monmouth Junction, NJDirectorFranklin Berger · Framingham, MADirectorGary Sollis · Vancouver, British Columbia, CanadaDirectorRichard Glickman · Vancouver, British Columbia, CanadaDirectorJohn A. Martin · Newtown, PADirectorPeter Virsik · Portola Valley, CAExecDavid Parkinson · Houston, TXExec · DirectorOtello A. Stampacchia · Boston, MADirectorAnn M. Thorell · Malvern, PADirectorDavid Wood · Englewood, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗